Cargando…
Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest
BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, including gefitinib, are first-line drugs against advanced non-small cell lung cancer with activating EGFR mutations. However, the development of resistance to such drugs is a major clinical challenge. METHODS: The role...
Autores principales: | Zhou, Jian, Chang, Meijia, Li, Jing, Fang, Tao, Hu, Jie, Bai, Chunxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963077/ https://www.ncbi.nlm.nih.gov/pubmed/29784046 http://dx.doi.org/10.1186/s12931-018-0804-1 |
Ejemplares similares
-
Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling
por: Zhang, Ge, et al.
Publicado: (2018) -
Knockdown of PLAT enhances the anticancer effect of gefitinib in non-small cell lung cancer
por: Yan, Mengnan, et al.
Publicado: (2020) -
Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway
por: Zhou, Jian, et al.
Publicado: (2019) -
Knockdown of Annexin A2 Enhances Radiosensitivity by Increasing G2/M-Phase Arrest, Apoptosis and Activating the p38 MAPK-HSP27 Pathway in Nasopharyngeal Carcinoma
por: He, Huocong, et al.
Publicado: (2022) -
Impaired G2/M cell cycle arrest induces apoptosis in pyruvate carboxylase knockdown MDA-MB-231 cells
por: Rattanapornsompong, Khanti, et al.
Publicado: (2021)